A Trump family-linked investment group has agreed to back XWELL, Inc. (NASDAQ:XWEL) , a wellness and biosecurity company planning to deploy AI-powered infectious disease screening at U.S. airports during the 2026 FIFA World Cup, reported the Financial Times .
American Ventures, a special purpose vehicle managed by Trump Tower-based broker Dominari Securities, agreed in late February to purchase $31.3 million of convertible preferred shares in XWell. At the time, XWell carried a market capitalisation of under $3 million.
The 31,333 preferred shares were priced at $1,000 each, convertible into 66.6 million common shares at an initial conversion price of $0.47, according to securities filings.
AI Screening At Scale
The investment closed three weeks after XWell partnered with AI predictive analysis start-up PieQ. The two companies plan to deploy what they describe as a “next generation intelligence layer” to manage anticipated travel surges around major international …
This post was originally published here